论文部分内容阅读
目的探讨分析三联疗法治疗HP相关性胃炎的临床效果。方法随机选取2011年02月份-2012年04月份就诊于我院的213例HP相关性胃炎作为研究对象,其中107例采用三联疗法治疗(观察组),另106例采用奥美拉唑治疗(对照组),分析比较两组患者的治疗效果。结果观察组患者总有效率(治愈+缓解)为80.9%;对照组患者总有效率为61.3%;两组患者临床情况,经统计分析,差异具有显著性(P<0.05)。结论三联疗法是治疗HP相关性胃炎的有效治疗方案,能够显著改善临床治疗效果。
Objective To investigate the clinical effect of triple therapy on HP-associated gastritis. Methods Two hundred and thirteen patients with HP-related gastritis treated in our hospital from February 2011 to April 2012 were randomly selected, of whom 107 were treated with triple therapy (observation group) and 106 were treated with omeprazole (control Group), analysis and treatment of two groups of patients. Results The total effective rate (cure + remission) was 80.9% in the observation group and 61.3% in the control group. The clinical status of the two groups was statistically significant (P <0.05). Conclusions Triple therapy is an effective treatment for HP-associated gastritis and can significantly improve the clinical outcome.